Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Topical Treatments and PDT for Actinic Keratosis
NCT02281682Phase 4Unknown
- Sponsor
- Maastricht University Medical Center+
- Start
- Nov 2014
- Primary completion
- Jul 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ingenol mebutate in actinic keratosis (AK), sponsored by Maastricht University Medical Center+. Status: unknown.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02281682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02281682.